| In short |
|
Stomach cancer is a devastating and devastating disease that affects more and more young people around the world. However, recent research reveals that three quarters of future cases could be avoided thanks to appropriate screening and treatment of a common bacterial infection: Helicobacter pylori. This bacteria, when it settles chronically, represents the most significant risk factor for gastric cancer. Fortunately, it is avoidable and treatable thanks to a combination of antibiotics and inhibitors of the proton pump (IPP). These treatments reduce the acidity produced in the stomach, thereby reducing the risk of cancer.
The disturbing rise in gastric cancer in young people
Despite the possibility of preventing this disease, an alarming increase in cases of stomach cancer in those under 50 is noted. Research by the International Research on Cancer Agency (IARC), affiliated with the World Health Organization (WHO), project a future incidence of gastric cancer, especially in people born between 2008 and 2017. These studies use a large -scale model to estimate the future burden of gastric cancer by assuming the absence of changes in current prevention or treatment strategies.
Researchers have highlighted that if current treatment practices are unchanged, around 15.6 million new cases of gastric cancer will appear during the life of people born during this period. Among these cases, 76 % are attributable to an infection by H. pyloriand therefore potentially avoidable. Asia should bear the heaviest load with 10.6 million cases, followed by the Americas (2 million) and Africa (1.7 million).
“What your poop is hiding can kill you”: a chilling discovery connects the stool to an imminent death
The advantages of an effective screening and treatment program
A screening and treatment program of H. pylori Efficient at 100 % could reduce cases of gastric cancer up to 75 %. Even programs with an efficiency of 80 to 90 % could prevent between 60 and 68 % of cases. These strategies prove to be economically viable, even in low -income environments, and comparable to vaccination campaigns for human papillomavirus (HPV) or hepatitis B. The researchers highlight the importance of redirecting attention to the life course of young people of today and their prospects for the development of gastric cancer, with or without interventions.
However, these initiatives require increased investments in the prevention of gastric cancer, including the implementation of screening and processing strategies. It is also underlined the need to develop a vaccine against H. pylori To strengthen these prevention efforts.
An artificial heart broke all records: this patient survives 105 days with an organ never seen before in medicine
Limits and challenges encountered by the study
This study has certain limits. Many low-income countries lack reliable cancer registers, especially in Africa, which can lead to an underestimation of cases. In addition, certain data concerning the location of gastric cancer (upper or lower part of the stomach) were incomplete or imprecise. The simulation model used assumes that cancer incidence rates and screening practices remain constant over time, as well as the prevalence of H. pylori.
Despite these limitations, the results of the study point out that the majority of future cases of gastric cancer are avoidable thanks to better public health action. The eradication of H. pylori is a proven and affordable strategy that should be prioritized. Programs can be adapted to high, medium and low income countries, for example, using endoscopy -based screening and treatment supported by insurance for the former, and population screening and early treatment for the latter.
Ecolo influencers, NGOs, activists… Buy-des-fans.com, the site that increases their influence on social networks tenfold
Is a future of stomach cancer possible?
What this study teaches us is clear: gastric cancer remains an important threat to global health, especially for young generations. However, with targeted interventions based on evidence, such as screening and treatment of H. pyloriit is possible to save millions of lives. The question remains whether political decision -makers and health systems will be ready to invest in these preventive approaches to reverse the disturbing trend of this disease.
Faced with the challenges and opportunities presented, how can countries adapt their public health strategies to prevent this silent epidemic and protect future generations?
This article is based on verified sources and the assistance of editorial technologies.
Did you like it? 4.3/5 (20)
